Author/Authors :
Saadatnia, Mohammad Department of Neurology - Isfahan Neurosciences Research Center - Isfahan University of Medical Sciences, Isfahan, Iran , Naghavi, Neda Medical Student Research Center - Isfahan University of Medical Sciences, Isfahan, Iran , Fatehi, Farzad Department of Neurology - Tehran University of Medical Sciences, Tehran, Iran , Zare, Mohammad Department of Neurology - Isfahan Neurosciences Research Center - Isfahan University of Medical Sciences, Isfahan, Iran , Tajmirriahi, Marzieh Department of Neurology - Isfahan Neurosciences Research Center - Isfahan University of Medical Sciences, Isfahan, Iran
Abstract :
Background: Consumption of oral contraceptive pills (OCP) is a known risk factor for cerebral venous and sinus thrombosis
(CVST) among women. We determined whether misuse of OCP could increase the risk of CVST in women. Methods: A
case-control study was conducted from 2003 to 2007 on 64 female patients with CVST admitted to Al- Zahra medical center and
232 healthy age-matched female OCP users as controls. Patients and controls were interviewed and misuse of OCP was categorized
to taking OCP for self-treatment of dysfunctional uterine bleeding, for family planning without physician consult, or for delaying
menstruation in purpose of religious customs or traveling, and taking OCP in high dose during the preceding year. Results: Among
64 cases and 232 controls, 30 (46.9 %) and 63 (27.2 %), respectively, had a history of OCP misuse (Odds Ratio = 2.36, 95%
Confidence Intervals = 1.33 to 4.18, P = 0.002). Also, using cyproterone compound (Diane) was more frequent in the CVST group
(P<0.001). Multivariate analysis controlling for age, OCP misuse, type of OCP, and history of coagulopathy showed that OCP misuse
(P<0.001) and using Diane as the OCP (P = 0.006) were both independently associated with CVST. Discussion: OCP misuse can be
considered as an additional predisposing factor for CVST among women and partly responsible for larger proportion of female
patients with CVST. These findings should alarm the healthcare system to create strategies controlling the inappropriate use of
OCP among Iranian women.